NO995900D0 - Retroviral vector particles formed in a baculovirus expression system - Google Patents

Retroviral vector particles formed in a baculovirus expression system

Info

Publication number
NO995900D0
NO995900D0 NO995900A NO995900A NO995900D0 NO 995900 D0 NO995900 D0 NO 995900D0 NO 995900 A NO995900 A NO 995900A NO 995900 A NO995900 A NO 995900A NO 995900 D0 NO995900 D0 NO 995900D0
Authority
NO
Norway
Prior art keywords
expression system
retroviral vector
particles formed
baculovirus expression
vector particles
Prior art date
Application number
NO995900A
Other languages
Norwegian (no)
Other versions
NO995900L (en
Inventor
Alan John Kingsman
Ian Martin Jones
Original Assignee
Oxford Biomedica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica Ltd filed Critical Oxford Biomedica Ltd
Publication of NO995900D0 publication Critical patent/NO995900D0/en
Publication of NO995900L publication Critical patent/NO995900L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14144Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051Methods of production or purification of viral material
    • C12N2740/15052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
NO995900A 1997-06-04 1999-12-02 Retroviral vector particles formed in a baculovirus expression system NO995900L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems
PCT/GB1998/001626 WO1998055640A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system

Publications (2)

Publication Number Publication Date
NO995900D0 true NO995900D0 (en) 1999-12-02
NO995900L NO995900L (en) 2000-02-04

Family

ID=10813571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995900A NO995900L (en) 1997-06-04 1999-12-02 Retroviral vector particles formed in a baculovirus expression system

Country Status (11)

Country Link
EP (1) EP0986649A1 (en)
JP (1) JP2002510204A (en)
KR (1) KR20010013332A (en)
CN (1) CN1259171A (en)
AU (1) AU741764B2 (en)
CA (1) CA2289491A1 (en)
GB (1) GB9711578D0 (en)
IL (1) IL132359A0 (en)
NO (1) NO995900L (en)
NZ (1) NZ500936A (en)
WO (1) WO1998055640A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073424A1 (en) * 1999-05-28 2000-12-07 Mount Sinai School Of Medicine A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
CA2422956C (en) 2000-10-23 2010-10-19 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
TWI477602B (en) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
EP2241626B1 (en) * 2008-01-09 2016-01-06 Konkuk University Industrial Cooperation Corp Baculovirus-based vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2252088A (en) * 1987-07-24 1989-03-01 Cetus Corporation Airlift insect cell culture
WO1989009271A1 (en) * 1988-03-21 1989-10-05 Viagene, Inc. Recombinant retroviruses
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9510272D0 (en) * 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors

Also Published As

Publication number Publication date
NZ500936A (en) 2001-11-30
GB9711578D0 (en) 1997-07-30
AU741764B2 (en) 2001-12-06
JP2002510204A (en) 2002-04-02
IL132359A0 (en) 2001-03-19
EP0986649A1 (en) 2000-03-22
NO995900L (en) 2000-02-04
CN1259171A (en) 2000-07-05
AU7780098A (en) 1998-12-21
CA2289491A1 (en) 1998-12-10
WO1998055640A1 (en) 1998-12-10
KR20010013332A (en) 2001-02-26

Similar Documents

Publication Publication Date Title
ATE324456T1 (en) PROTEIN EXPRESSION IN BACULOVIRUS VECTOR EXPRESSION SYSTEMS
DE69840111D1 (en) ATM
ID20560A (en) CLOTHES ONLY USE
DE59813068D1 (en) COATING MATERIALS
ID21194A (en) D-PROLINA'S DEMONS
ID22134A (en) DETERGENT PARTICLES
NO996108D0 (en) 9 oksinerytromycinderivater
NO974640L (en) swivel
DE69608823D1 (en) Mail merge
ID23861A (en) AMINOPIRIMIDINE'S DEMONS
ID19801A (en) 5'-DEOKSI-SITIDINA
IT1291353B1 (en) PEPTIDES WITH ANTIVIRAL ACTIVITY
NO995900D0 (en) Retroviral vector particles formed in a baculovirus expression system
DE69828937D1 (en) Piece d'interposition
NO20003359D0 (en) swivel
DE69824987D1 (en) soleplate
NO993735D0 (en) swivel
FR2758444B1 (en) EARINGS
DE29716262U1 (en) Plastic can
FR2771994B1 (en) CRAFT FOR HOUSEHOLD USE
KR980000542U (en) Sorter
DE69830516D1 (en) COPOLYESTER OBJECT
DE29718340U1 (en) Garment
DE29701077U1 (en) Voluminous textile composite
FI972196A0 (en) A calender

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application